On this page
This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.
Overview
Product & regulatory status
Investigational in the cited celiac disease study.
Intestinal barrier rationale
Larazotide was evaluated to influence tight-junction regulation and symptoms rather than to remove the underlying immune trigger. [1]
What the evidence shows
What was tested
A randomized trial enrolled 342 adults who had followed a gluten-free diet for at least a year. They continued that diet during twelve weeks of study treatment. [1]
Mixed results across groups
One studied treatment group improved the primary symptom score versus placebo; the other two did not. This pattern matters and does not support a simple more-is-better assumption. [1]
What remains unknown
This study does not establish a cure for celiac disease, permission to eat gluten, or effectiveness for undiagnosed “leaky gut.”
Safety
Safety context
Safety was comparable with placebo during the trial. The relatively short, selected-population study does not resolve uncommon events or long-term safety. [1]
Studied setting
The evidence concerns an oral investigational preparation in celiac disease. It cannot be transferred to a different route or an unrelated gastrointestinal condition. [1]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [2]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [3]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Would it replace a gluten-free diet?
No. The cited research explicitly kept participants on their gluten-free diet; it investigated an adjunct.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial2015 · Primary research · PubMed
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.